https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-closing-of-%24100-million-public-follow-on-offering-and
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-pricing-of-public-offering-of-common-stock-2021-12-08
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-proposed-follow-on-offering-of-common-stock-2021-12-07
https://www.nasdaq.com/press-release/adicet-bio-announces-positive-interim-clinical-data-from-first-ever-allogeneic-off
https://www.nasdaq.com/press-release/adicet-bio-to-host-webcast-presentation-of-adi-001-interim-clinical-data-in-b-cell
https://www.nasdaq.com/press-release/adicet-announces-appointment-of-dr.-michael-g.-kauffman-to-the-board-of-directors
https://www.nasdaq.com/press-release/adicet-presents-preclinical-data-for-adi-002-a-gpc3-targeted-development-candidate
https://www.nasdaq.com/press-release/adicet-reports-third-quarter-2021-financial-results-and-provides-business-updates
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-stifel-2021-virtual-healthcare-conference-2021-11-08
https://www.nasdaq.com/press-release/adicet-announces-trials-in-progress-poster-presentation-for-adi-001-at-2021-ash
https://www.nasdaq.com/press-release/adicet-announces-promotion-of-blake-aftab-ph.d.-to-chief-scientific-officer-2021-10
https://www.nasdaq.com/press-release/adicet-to-present-preclinical-data-from-allogeneic-gamma-delta-t-cell-platform-at
https://www.nasdaq.com/press-release/twist-bioscience-collaborates-with-adicet-bio-to-accelerate-discovery-of-gamma-delta
https://www.nasdaq.com/press-release/adicet-bio-collaborates-with-twist-bioscience-to-accelerate-discovery-of-gamma-delta
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2021-09-02
https://www.nasdaq.com/press-release/adicet-reports-second-quarter-2021-financial-results-and-provides-business-updates
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2021-08-02
https://www.nasdaq.com/press-release/adicet-bio-announces-formation-of-scientific-advisory-board-2021-07-15
https://www.nasdaq.com/press-release/adicet-bio-added-to-the-russell-2000r-index-2021-06-28
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2021-05-18
https://www.nasdaq.com/press-release/adicet-reports-first-quarter-2021-financial-results-and-provides-business-updates
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-fireside-chat-at-the-7th-annual-truist-securities-life
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-the-canaccord-genuity-2021-horizons-in-oncology-virtual
https://www.nasdaq.com/press-release/adicet-bio-appoints-dr.-blake-aftab-as-vice-president-of-research-2021-04-13
https://www.nasdaq.com/press-release/adicet-reports-fourth-quarter-and-full-year-2020-financial-results-and-provides
https://www.nasdaq.com/press-release/adicet-bio-announces-initiation-of-its-first-in-human-phase-1-trial-of-adi-001-for
https://www.nasdaq.com/press-release/adicet-bio-appoints-dr.-andrew-sinclair-to-its-board-of-directors-2021-03-04
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-closing-of-%24152-million-public-offering-and-concurrent
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2021-02-11
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-pricing-of-%24135-million-public-offering-of-common-stock-and
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-proposed-public-offering-of-common-stock-and-concurrent
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2021-01-07
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-fireside-chat-at-jmp-securities-hematology-summit-2020
https://www.nasdaq.com/press-release/adicet-announces-appointment-of-dr.-bastiano-sanna-to-its-board-of-directors-2020-12
https://www.nasdaq.com/press-release/adicet-bio-to-participate-in-upcoming-investor-conferences-2020-11-06
https://www.nasdaq.com/press-release/adicet-reports-third-quarter-2020-financial-results-and-provides-business-update-2020
https://www.nasdaq.com/press-release/adicet-appoints-don-healey-ph.d.-as-chief-technology-officer-2020-10-26
https://www.nasdaq.com/press-release/adicet-announces-fda-clearance-of-ind-application-for-first-in-class-allogeneic-car
https://www.nasdaq.com/press-release/adicet-bio-to-present-at-the-jefferies-cell-therapy-summit-2020-10-01
https://www.nasdaq.com/press-release/adicet-bio-inc.-determines-not-to-proceed-with-public-offering-of-common-stock-2020
https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-proposed-public-offering-of-common-stock-2020-09-21
https://www.nasdaq.com/press-release/adicet-bio-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-2020-09-18
https://www.nasdaq.com/press-release/adicet-announces-completion-of-merger-with-restorbio-2020-09-15
https://www.nasdaq.com/press-release/adicet-bio-receives-%2410-million-product-development-milestone-from-regeneron-2020-08
https://www.nasdaq.com/press-release/restorbio-provides-corporate-update-and-reports-second-quarter-2020-financial-results
https://www.nasdaq.com/press-release/restorbio-and-trialspark-collaborate-to-investigate-rtb-101-for-covid-19-on-the
https://www.nasdaq.com/press-release/restorbio-announces-an-award-from-the-national-institute-on-aging-to-fund-a-pilot
https://www.nasdaq.com/press-release/aceto-sell-its-chemicals-business-assets-new-mountain-capital-2019-04-21
https://www.nasdaq.com/press-release/aceto-receives-court-approval-stalking-horse-agreement-sell-rising-pharmaceuticals
https://www.nasdaq.com/press-release/aceto-enters-stalking-horse-agreement-sell-rising-pharmaceuticals-2019-04-11
https://www.nasdaq.com/press-release/aceto-announces-receipt-nasdaq-notice-due-delay-filing-form-10-q-fiscal-quarter-ended
https://www.nasdaq.com/press-release/aceto-announces-proposed-sale-its-chemicals-business-assets-new-mountain-capital-338
